HeartSciences (HSCS) Competitors $3.44 +0.11 (+3.30%) Closing price 10/20/2025 04:00 PM EasternExtended Trading$3.52 +0.08 (+2.18%) As of 10/20/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. PETV, DRIO, MODD, RBOT, POCI, STRR, NRXS, CLGN, RVP, and VVOSShould you be buying HeartSciences stock or one of its competitors? The main competitors of HeartSciences include PetVivo (PETV), DarioHealth (DRIO), Modular Medical (MODD), Vicarious Surgical (RBOT), Precision Optics (POCI), Star Equity (STRR), NeurAxis (NRXS), CollPlant Biotechnologies (CLGN), Retractable Technologies (RVP), and Vivos Therapeutics (VVOS). These companies are all part of the "medical equipment" industry. HeartSciences vs. Its Competitors PetVivo DarioHealth Modular Medical Vicarious Surgical Precision Optics Star Equity NeurAxis CollPlant Biotechnologies Retractable Technologies Vivos Therapeutics HeartSciences (NASDAQ:HSCS) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings, valuation and media sentiment. Do analysts rate HSCS or PETV? HeartSciences currently has a consensus target price of $10.50, indicating a potential upside of 205.23%. Given HeartSciences' stronger consensus rating and higher probable upside, equities research analysts plainly believe HeartSciences is more favorable than PetVivo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, HSCS or PETV? HeartSciences has a beta of 2.57, suggesting that its share price is 157% more volatile than the S&P 500. Comparatively, PetVivo has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Does the media prefer HSCS or PETV? In the previous week, HeartSciences had 2 more articles in the media than PetVivo. MarketBeat recorded 3 mentions for HeartSciences and 1 mentions for PetVivo. PetVivo's average media sentiment score of 1.75 beat HeartSciences' score of 0.33 indicating that PetVivo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PetVivo 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders and institutionals have more ownership in HSCS or PETV? 17.2% of HeartSciences shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 1.8% of HeartSciences shares are owned by company insiders. Comparatively, 10.8% of PetVivo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has stronger earnings and valuation, HSCS or PETV? HeartSciences has higher earnings, but lower revenue than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeartSciences$6.25K1,457.46-$8.77M-$8.30-0.41PetVivo$1.05M41.93-$10.95M-$0.40-3.33 Is HSCS or PETV more profitable? HeartSciences has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. HeartSciences' return on equity of -383.38% beat PetVivo's return on equity.Company Net Margins Return on Equity Return on Assets HeartSciencesN/A -383.38% -145.28% PetVivo -902.82%-4,813.07%-281.78% SummaryHeartSciences beats PetVivo on 11 of the 16 factors compared between the two stocks. Get HeartSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeartSciencesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.82M$2.25B$6.14B$10.55BDividend YieldN/AN/A5.72%4.84%P/E Ratio-0.4140.6129.4727.34Price / Sales1,457.4644.69580.96227.67Price / CashN/A59.9325.8230.35Price / Book19.1112.7912.526.69Net Income-$8.77M-$65.79M$3.32B$276.46M7 Day Performance-2.82%-0.95%1.81%-0.08%1 Month Performance-1.43%6.39%8.81%3.93%1 Year Performance-5.49%30.76%64.29%33.89% HeartSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeartSciences2.9041 of 5 stars$3.44+3.3%$10.50+205.2%-3.4%$8.82M$6.25K-0.4110Short Interest ↓Gap UpPETVPetVivoN/A$1.26+3.3%N/A+146.4%$36.90M$1.05M-2.8020Gap DownDRIODarioHealth1.9451 of 5 stars$14.38-3.7%$40.00+178.2%-22.3%$33.99M$27.04M0.00200Gap UpMODDModular Medical1.1456 of 5 stars$0.58-5.8%N/A-72.5%$33.98MN/A0.0020Short Interest ↓Gap UpHigh Trading VolumeRBOTVicarious Surgical1.7564 of 5 stars$6.24+9.9%$7.00+12.2%-21.9%$33.69MN/A0.00210Gap UpPOCIPrecision Optics0.2589 of 5 stars$4.23-0.2%N/A-0.2%$32.71M$19.09M0.0080STRRStar Equity0.9872 of 5 stars$11.13-0.9%$5.00-55.1%+173.9%$30.96M$140.06M0.001,300NRXSNeurAxis1.7425 of 5 stars$3.03-1.3%$7.00+131.0%+21.9%$29.92M$3.22M-1.6519Gap DownCLGNCollPlant Biotechnologies1.9626 of 5 stars$2.32+3.6%$11.50+395.7%-40.5%$28.48M$510K0.0070News CoverageAnalyst ForecastGap UpRVPRetractable Technologies2.4886 of 5 stars$0.92-5.2%N/A+28.9%$27.46M$38.16M-1.70240Positive NewsShort Interest ↓Gap UpVVOSVivos Therapeutics1.7251 of 5 stars$3.18+0.3%$4.92+54.6%+6.7%$23.79M$15.03M0.00160News CoverageShort Interest ↑ Related Companies and Tools Related Companies PetVivo Competitors DarioHealth Competitors Modular Medical Competitors Vicarious Surgical Competitors Precision Optics Competitors Star Equity Competitors NeurAxis Competitors CollPlant Biotechnologies Competitors Retractable Technologies Competitors Vivos Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 10/21/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartSciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSCS Stock Alerts